Literature DB >> 25827601

Sweetless'n low LDL-C targets for PCSK9 treatment.

Baris Gencer1, François Mach2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25827601     DOI： 10.1093/eurheartj/ehv056

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  2 in total

1.  OSLER and ODYSSEY LONG TERM: PCSK9 inhibitors on the right track of reducing cardiovascular events.

Authors:  Mohamed Hassan
Journal:  Glob Cardiol Sci Pract       Date:  2015-06-26

2.  Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study.

Authors:  Jing Gao; Hai-Bo Wang; Jian-Yong Xiao; Min Ren; Kathleen Heather Reilly; Yu-Ming Li; Yin Liu
Journal:  BMJ Open       Date:  2018-07-10       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.